miR-302 cluster inhibits angiogenesis and growth of K562 leukemia cells by targeting VEGFA

Background miR-302 cluster has been reported as a tumor suppressor in many human cancers; yet, its function in chronic myeloid leukemia (CML) tumorigenesis remains largely unclear. The study was aimed to explore the functional roles of miR-302 cluster in CML progression.